Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can Smartphone-Based oximeters save kids with pneumonia?

NCT ID NCT05914324

First seen Dec 10, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This study is testing two new types of pulse oximeters—simple devices that measure oxygen levels—for babies and toddlers with pneumonia in Cape Town, South Africa. Researchers want to see if these devices help healthcare workers correctly identify children with low oxygen and refer them for care. About 936 children under 2 years old will take part, and the goal is to improve pneumonia management in low-resource settings.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY TRACT INFECTIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Desmond Tutu TB Centre

    Cape Town, Western Cape, 7505, South Africa

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Phefumla device and LB-01 device (pulse oximeters)

What this could lead to

If successful, this could show that affordable, easy-to-use pulse oximeters help healthcare workers correctly identify and refer children with dangerously low oxygen levels, potentially reducing deaths from pneumonia in low-resource settings.

What could go wrong

This is an observational/device evaluation study, not a treatment trial. The devices may not perform as well as expected in real-world conditions, and results may not apply to other regions or populations.

Conditions

The condition(s) this trial relates to.

Hypoxia respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.